Key points are not available for this paper at this time.
Design
Review
Apolipoprotein B is highlighted as a robust, particle-based metric for assessing atherosclerotic cardiovascular disease risk.
Apolipoprotein B (apoB) has emerged as a robust, particle-based metric for assessing atherosclerotic cardiovascular disease (ASCVD) risk [1]. Despite growing evidence showing its superiority over c...
No takes yet. Share an insight, caveat, or question.
Zubirán et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: